AI assistant
Sending…
Replimune Group, Inc. — Director's Dealing 2025
Dec 19, 2025
33193_dirs_2025-12-19_fe58df96-9050-419c-8237-9a14fd383070.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2025-12-19
Reporting Person: Patel Sushil (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-19 | Common Stock | A | 200000 | — | Acquired | 533576 | Direct |
Footnotes
F1: Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 50% of the RSUs will vest on November 15, 2026 and 50% of the RSUs will vest on November 15, 2027, subject to the Reporting Person's continuous service to the Issuer.
More from Replimune Group, Inc.
Director's Dealing
2026
Feb 20
Major Shareholding Notification
2026
Feb 17
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Regulatory Filings
2026
Jan 12
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 11